{"id":"W2012003343","doi":"10.1007/s40265-013-0026-2","title":"Pediatric Relapsed or Refractory Leukemia: New Pharmacotherapeutic Developments and Future Directions","year":2013,"lang":"en","type":"review","venue":"Drugs","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Medicine; Leukemia; Refractory (planetary science); Myeloid leukemia; Oncology; Disease; Chemotherapy; Cancer; Childhood leukemia; Intensive care medicine; Internal medicine; Lymphoblastic Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0002317891,0.0006423953,0.001654243,0.0006192538,0.0001703696,0.00006792368,0.0002791157,0.0007439295,0.001428317],"category_scores_gemma":[0.00009083598,0.0004228391,0.0002608704,0.001035111,0.00007537737,0.0001427924,0.000164151,0.001344545,0.001168155],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003052585,"about_ca_system_score_gemma":0.01255998,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000101186,"about_ca_topic_score_gemma":0.000002390103,"domain_scores_codex":[0.997095,0.0001675174,0.0007153247,0.0007293404,0.0006685241,0.0006242894],"domain_scores_gemma":[0.9978851,0.0004931986,0.0003044629,0.0005030451,0.0001262771,0.0006879219],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003846142,0.00004564074,0.000006369301,0.008433134,0.0003746742,0.00007674043,0.000284961,6.86063e-9,9.854796e-7,0.00000483186,0.06210699,0.9286272],"study_design_scores_gemma":[0.002315421,0.00009733898,0.00002418766,0.00159561,0.002271889,0.000481055,0.00005100768,0.000005857861,0.000001201649,0.000004426907,0.9927393,0.0004127123],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005842372,0.9938931,0.00001099706,0.000181725,0.0008970888,0.001739919,0.00002223277,0.0001759807,0.003020488],"genre_scores_gemma":[0.000001480373,0.9452348,0.001200455,0.0003403643,0.004250085,0.0002422122,0.0001296119,0.0001764491,0.04842458],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9306323,"threshold_uncertainty_score":0.9998223,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04661065883241636,"score_gpt":0.3592068213984452,"score_spread":0.3125961625660288,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}